| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |